REFERENCES
- Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586–597
- Kurtzman G, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukemia. Lancet 1988; 2: 1159–1162
- Frickhofen N, Abkowitz J, Safford M, et al. Persistent parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Int Med 1990; 113: 926–933
- Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red cell aplasia of 10 years’duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321: 519–523
- Choi SH, Chang SP, Won JC, et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis. 2002; 34: 71–75
- Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant. 2001; 5: 320–330
- Plentz A, Hahn J, Holler E, Jilg W, Modrow S. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation. J Clin Virol 2004; 31: 16–19
- Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 2000; 14: 586–591
- Klar A, Halamish A, Shoseyov D, et al. Chronic human parvovirus B19 infection associated with interstitial lung disease. Isr Med Assoc J 2002; 4: 825–826
- Sanphasitvong W, Poovorawan K, Boonsuk P, Assanasen T, Na Nakorn T, Poovorawan Y. Parvovirus b19 infection in HIV patient with pure red cell aplasia. Southeast Asian J Trop Med Public Health 2005; 36: 1216–1220
- Chuhjo T, Nakao S, Matsuda T. Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin. Am J Hematol. 1999; 60: 222–224
- Brown KE, Young NS, Liu JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol. 1994; 16: 1–31
- Isobe Y, Sugimoto K, Shiraki Y, Nishitani M, Koike K, Oshimi K. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy. Am J Hematol 2004; 77: 370–373
- Hayes-Lattin B, Seipel TJ, Gatter K, Heinrich MC, Maziarz RT. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation. Am J Hematol 2004; 75: 142–145
- Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985; 152: 257–265